Literature DB >> 4206096

Editorial: Somatostatin: newcomer from the hypothalamus.

P Brazeau, R Gullemin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4206096     DOI: 10.1056/NEJM197404252901711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.

Authors:  H Wagner; E Zierden; W H Hauss
Journal:  Klin Wochenschr       Date:  1975-06-01

Review 2.  Somatostatin in portal hypertension.

Authors:  J S Morgan; R J Groszmann
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

3.  Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.

Authors:  Jonathan Strosberg; Larry Kvols
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

4.  [Somatostatin -- a review (author's transl)].

Authors:  C Lucke; H J Mitzkat; A von zur Mühlen
Journal:  Klin Wochenschr       Date:  1976-04-01

Review 5.  Treatment of pituitary tumors: somatostatin.

Authors:  Maria A Tichomirowa; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

6.  Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.

Authors:  R G Long; J R Peters; S R Bloom; M R Brown; W Vale; J E Rivier; D G Grahame-Smith
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

7.  Coagulation studies and platelet function after somatostatin infusion.

Authors:  H Rasche; S Raptis; R Scheck; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-10-15

8.  Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms.

Authors:  Tara A Schwetz; Alessandro Ustione; David W Piston
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

9.  Somatostatin inhibits the mitogenic effect of thyroliberin.

Authors:  M Pawlikowski; J Kunnert-Radek; H Stepień
Journal:  Experientia       Date:  1978-02-15

Review 10.  Lanreotide Autogel: a review of its use in the management of acromegaly.

Authors:  Jamie D Croxtall; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.